CMV co‐infection and risk of AIDS and non‐AIDS events in a large cohort of HIV‐infected patients

摘要

In HIV‐positive patients (pts), CMV co‐infection has been proposed as a key factor in sustaining immune activation, which in turn could play a role in determining immune senescence. We evaluated the prevalence and predictors of CMV co‐infection in a cohort of HIV+ pts and assessed the impact of CMV co‐infection on the risk of AIDS and non‐AIDS events. We included pts in the ICONA study with10 cp/mL higher 1.05 0.96–1.16 0.26 Years from HIV diagnosis per 5 years longer 1.02 0.90–1.17 0.69 ART experienced vs. na?ve at baseline 0.94 0.66–1.36 0.77